| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,8422 | +1,29 % | €720,20M | €500,79 | |
| €41,6005 | +0,77 % | €719,77M | €756,77 | |
| €17,8019 | +0,16 % | €718,73M | €1,82K | |
EVC Entravision Communication | €7,5858 | -2,64 % | €717,87M | €69,53K | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €25,2975 | +1,90 % | €716,48M | €4,99K | |
| €23,3768 | +0,27 % | €714,88M | €31,78 | |
AMPH Amphastar Pharmaceuticals, Inc. | €16,2196 | +0,97 % | €713,95M | €1,58K | |
MATW Matthews International Corp | €21,8315 | -0,37 % | €711,34M | €3,94K | |
TBPH Theravance Biopharma, Inc. | €14,2336 | +1,22 % | €711,20M | €6,10K | |
MPB Mid Penn Bancorp, Inc. | €27,9218 | +0,08 % | €710,83M | €2,43K | |
KRO Kronos Worldwide, Inc. | €5,8206 | -1,22 % | €710,59M | €5,47K | |
ADAM Adamas Trust, Inc. Common Stock | €7,7740 | -0,55 % | €710,15M | €133,14 | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €18,7838 | +0,49 % | €708,58M | €0,859 | |
ROOT Root, Inc. Class A Common Stock | €45,8139 | +1,32 % | €707,74M | €4,34K | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,0219 | -0,37 % | €707,22M | €4,81K | |
